Yoshikatsu Kanai

Active 1992–2025

163
Papers
33,518
Citations
104
h-index
158
i10-index

Citations

Citations per year for Yoshikatsu Kanai1981: 1 citations1985: 1 citations1988: 1 citations1992: 3 citations1993: 27 citations1994: 57 citations1995: 63 citations1996: 81 citations1997: 141 citations1998: 178 citations1999: 203 citations2000: 293 citations2001: 352 citations2002: 439 citations2003: 399 citations2004: 430 citations2005: 314 citations2006: 249 citations2007: 276 citations2008: 420 citations2009: 274 citations2010: 253 citations2011: 260 citations2012: 288 citations2013: 288 citations2014: 334 citations2015: 261 citations2016: 271 citations2017: 259 citations2018: 259 citations2019: 870 citations2020: 1,112 citations2021: 919 citations2022: 721 citations2023: 531 citations2024: 882 citations2025: 344 citations2026: 4 citations1982–1984: no citations, so these years are not shown1986–1987: no citations, so these years are not shown1989–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,488 citing papers, 26.8% of this breakdownChina: 1,054 citing papers, 11.3% of this breakdownJapan: 956 citing papers, 10.3% of this breakdownGermany: 584 citing papers, 6.3% of this breakdownUnited Kingdom: 544 citing papers, 5.9% of this breakdownCanada: 308 citing papers, 3.3% of this breakdownFrance: 283 citing papers, 3% of this breakdownItaly: 262 citing papers, 2.8% of this breakdownSwitzerland: 230 citing papers, 2.5% of this breakdownAustralia: 221 citing papers, 2.4% of this breakdownSpain: 214 citing papers, 2.3% of this breakdownNetherlands: 183 citing papers, 2% of this breakdown
0%26.8%Other 21.1%

Fields

  • Medicine41.4%
  • Biochemistry, Genetics and Molecular Biology32.6%
  • Neuroscience17.6%
  • Immunology and Microbiology2.2%
  • Agricultural and Biological Sciences1.8%
  • Environmental Science1.2%
  • Other3.2%

Topics

  • Amino Acid Enzymes and Metabolism7.1%
  • Neuroscience and Neuropharmacology Research5.7%
  • Drug Transport and Resistance Mechanisms4.7%
  • Gout, Hyperuricemia, Uric Acid2.8%
  • Epigenetics and DNA Methylation2.7%
  • Metabolism and Genetic Disorders2.4%
  • Other74.6%

Coauthors

All papers

Open in search
  1. Amino acid transporters revisited: New views in health and disease

    Authors: , , , - Trends in Biochemical Sciences 2018 cited by 480

  2. The SLC3 and SLC7 families of amino acid transporters

    Authors: , , - Molecular Aspects of Medicine 2013 cited by 689

  3. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics

    Authors: - Pharmacology & Therapeutics 2021 cited by 304

  4. Molecular identification of a renal urate–anion exchanger that regulates blood urate levels

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2002 cited by 1,551

  5. Impaired Amino Acid Transport at the Blood Brain Barrier Is a Cause of Autism Spectrum Disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell 2016 cited by 370

  6. Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)

    Authors: , , , , , - Journal of Biological Chemistry 1998 cited by 1,105

  7. Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate

    Authors: , , , , , , , , , , - Neuron 1996 cited by 2,541

  8. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines

    Authors: , , , , , , , , , , , , , , , , , , , - Biochimica et Biophysica Acta (BBA) - Biomembranes 2001 cited by 739

  9. Slc3a2 Mediates Branched-Chain Amino-Acid-Dependent Maintenance of Regulatory T Cells

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Reports 2017 cited by 140

  10. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2

    Authors: , , , , , , , , , - Cancer Science 2015 cited by 188

  11. The SLC1 high-affinity glutamate and neutral amino acid transporter family

    Authors: , , , , , , - Molecular Aspects of Medicine 2013 cited by 327

  12. Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application

    Authors: , , , - Pflügers Archiv - European Journal of Physiology 2020 cited by 121

  13. CATs and HATs: the SLC7 family of amino acid transporters

    Authors: , , , , , - Pflügers Archiv - European Journal of Physiology 2004 cited by 710

  14. l‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth

    Authors: , , , , , , , , , , - Cancer Science 2009 cited by 270

  15. Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoshikatsu Kanai, Hiroshi Suzuki, Nobuyuki Hamajima, Nariyoshi Shinomiya - Science Translational Medicine 2009 cited by 435

  16. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc

    Authors: , , , , , , , , , , , , , , , , - Nature Structural & Molecular Biology 2019 cited by 179

  17. Identification and Functional Characterization of a Na+-independent Neutral Amino Acid Transporter with Broad Substrate Selectivity

    Authors: , , , , , - Journal of Biological Chemistry 1999 cited by 500

  18. Mutations in Glucose Transporter 9 Gene SLC2A9 Cause Renal Hypouricemia

    Authors: , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2008 cited by 388

  19. CYP450s-Activity Relations of Celastrol to Interact with Triptolide Reveal the Reasons of Hepatotoxicity of Tripterygium wilfordii

    Authors: , , , , - Molecules 2019 cited by 75

  20. NPT1/SLC17A1 Is a Renal Urate Exporter in Humans and Its Common Gain‐of‐Function Variant Decreases the Risk of Renal Underexcretion Gout

    Authors: , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2014 cited by 91

  21. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation

    Authors: , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2020 cited by 73

  22. Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2

    Authors: , , , , , , , , , , , , - Nature Communications 2022 cited by 47

  23. Transport of Amino Acid-Related Compounds Mediated by L-Type Amino Acid Transporter 1 (LAT1): Insights Into the Mechanisms of Substrate Recognition

    Authors: , , , , , , , - Molecular Pharmacology 2002 cited by 406

  24. The 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier

    Authors: , , , , , , , , , , - Brain Research 2000 cited by 293